Publication highlights strengths of Memphasys’ antioxidant profiling system
Memphasys Ltd (ASX:MEM) has seen a boost to its proprietary antioxidant profiling…
Memphasys Limited. (ASX:MEM)
About Memphasys Limited.
Key Information
MEM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 13/03/2025 | MEM secures R&D Tax Rebate loan | 223.01KB | 2.3K |
| 28/02/2025 | Price Sensitive PS Half Yearly Report and Accounts | 1.77MB | 388 |
| 28/02/2025 | Price Sensitive PS Extension of Convertible Notes | 173.72KB | 813 |
| 25/02/2025 | Investor Presentation Feb 25 | 4.33MB | 10K |
| 24/02/2025 | Price Sensitive PS Felix Data lock complete and regulatory submission commenced | 235.7KB | 4.1K |
| 17/02/2025 | Price Sensitive PS Leading Brazilian Andrology Clinic to test Felix System | 225.1KB | 2.9K |
| 11/02/2025 | Price Sensitive PS Felix Clinical Trial complete, Data Lock expected in 2 weeks | 215.48KB | 4.6K |
| 23/01/2025 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 510.97KB | 2.7K |